Search Within

Shanu Modi

  1. "Gastrointestinal Oncology Service"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (3)
Groups
  1. Breast Medicine Service (8)
  2. Department of Medicine (8)
  3. Gastrointestinal Oncology Service (8)
  4. Solid Tumor Oncology Division (8)
  5. GSK Faculty (6)
  6. Hematologic Malignancies, Division of (6)

More Groups

People
  1. Yelena Janjigian (6)
  2. Gabriela Chiosis (5)
  3. Adriana Dionigi Corben (4)
  4. John Gerecitano (4)
  5. Komal Jhaveri (4)
  6. Mark Dunphy (4)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2020 (1)
  4. 2019 (1)
  5. 2015 (2)
  6. 2014 (1)
Publications
  1. Journal of Clinical Oncology (4)
  2. Cancer Cell (1)
  3. Cancer Research (1)
  4. Cell Reports (1)
  5. Expert Opinion on Investigational Drugs (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. Cell Press (2)
  3. American Association for Cancer Research (1)
  4. Taylor & Francis Group (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pooled analysis on characteristics of nausea and vomiting in patients receiving trastuzumab deruxtecan (T-DXd) in clinical studies
    Meeting Abstract

    Park, Y. H.; Cortes, J.; Modi, S.; Hurvitz, S. A.; Bianchini, G.; Iwata, H.; Shitara, K.; Siena, S.; Goto, Y.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A phase 1b, multicenter, open-label study of valemetostat in combination with DXd antibody drug conjugates (ADCs), trastuzumab deruxtecan (T-DXd) or datopotamab deruxtecan (Dato-DXd), in patients with solid tumors
    Meeting Abstract

    Sands, J.; Tolaney, S. M.; Ueno, N. T.; Spira, A. I.; Yamamoto, N.; Janjigian, Y. Y.; Naito, Y.; Damodaran, S.; Meric-Bernstam, F.; Modi, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • HER2 persistence after treatment with T-DXd in breast and gastrointestinal cancers
    Meeting Abstract

    Drago, J. Z.; Pareja, F.; Jhaveri, K. L.; Walsh, E. M.; Ku, G. Y.; Maron, S. B.; Janjigian, Y. Y.; Robson, M. E.; Reis-Filho, J. S.; Modi, S.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Molecular stressors engender protein connectivity dysfunction through aberrant N-glycosylation of a chaperone
    Journal Article

    Yan, P.; Patel, H. J.; Sharma, S.; Corben, A.; Wang, T.; Panchal, P.; Yang, C.; Sun, W.; Araujo, T. L.; Rodina, A.; more...
    Cell Reports (2020)

    Fulltext@MSK | Save
  • Paradigms for precision medicine in epichaperome cancer therapy
    Journal Article

    Pillarsetty, N.; Jhaveri, K.; Taldone, T.; Caldas-Lopes, E.; Punzalan, B.; Joshi, S.; Bolaender, A.; Uddin, M. M.; Rodina, A.; Yan, P.; more...
    Cancer Cell (2019)

    Fulltext@MSK | Save
  • Development of a noninvasive assay to determine drug concentration in tumor during hsp90 inhibitor therapy
    Meeting Abstract

    Taldone, T.; Pillarsetty, N.; Dunphy, M. P. S.; Gerecitano, J. F.; Caldas-Lopes, E.; Beattie, B.; Peter, R. I.; Kang, Y. L.; Rodina, A.; Yan, P.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase I trial of the HSP-90 inhibitor PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Rampal, R.; Drilon, A. E.; Fury, M. G.; Gounder, M. M.; Harding, J. J.; Hyman, D. M.; Varghese, A. M.; Voss, M. H.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Heat shock protein 90 inhibitors in the treatment of cancer: Current status and future directions
    Journal Article

    Jhaveri, K.; Ochiana, S. O.; Dunphy, M. P. S.; Gerecitano, J. F.; Corben, A. D.; Peter, R. I.; Janjigian, Y. Y.; Gomes DaGama, E. M.; Koren, J. 3rd; Modi, S.; more...
    Expert Opinion on Investigational Drugs (2014)

    Fulltext@MSK | Save